Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors

NCT05151341 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DIAGNOSTIC_TEST: Urine collection (150ml)
OTHER: Blood sample (20 ml)

Sponsor

Institut de Cancérologie de Lorraine

Collaborators

[object Object]